These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Clinical significance of TAC-41 assay as a tumor marker]. Ariyoshi Y, Kuwabara M, Iwakoshi N, Kito K. Nihon Rinsho; 1990 Feb; 48 Suppl():1060-3. PubMed ID: 2162412 [No Abstract] [Full Text] [Related]
10. [Clinical significance of CA 130 assay as a tumor marker]. Ariyoshi Y, Kuwabara M. Nihon Rinsho; 1990 Feb; 48 Suppl():985-8. PubMed ID: 2355640 [No Abstract] [Full Text] [Related]
11. [Clinical study of the NCC-ST-439 EIA kit using serum from patients with various types of cancer and benign disease (1)]. Ohkura H, Hattori N, Miyazaki I, Sawabu N, Tobe R, Kawai K, Abe O, Ishii M, Kawai T, Kamano T. Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1901-6. PubMed ID: 2439020 [Abstract] [Full Text] [Related]
12. [Study on the clinical usefulness of NCC-ST-439 in cases of digestive tract cancer]. Anzai K, Kurihara M, Izumi T. Nihon Gan Chiryo Gakkai Shi; 1990 Jul 20; 25(7):1437-47. PubMed ID: 2212836 [Abstract] [Full Text] [Related]
13. [NCC-ST-439]. Sugano K. Nihon Rinsho; 2005 Aug 20; 63 Suppl 8():681-3. PubMed ID: 16149610 [No Abstract] [Full Text] [Related]
14. [Clinical significance of DU-PAN-2 analysis as a tumor marker]. Sawabu N, Satomura Y. Nihon Rinsho; 1990 Feb 20; 48 Suppl():1003-7. PubMed ID: 2162408 [No Abstract] [Full Text] [Related]
20. [Serodiagnosis: tumor marker]. Yoneshima M, Hattori N, Sawabu N. Gan No Rinsho; 1988 Aug 20; 34(10):1209-15. PubMed ID: 2459425 [Abstract] [Full Text] [Related] Page: [Next] [New Search]